ライフサイエンスコーパス: needle biopsy

1 43% (181 true-positive findings of 419 core-needle biopsies).

2 lected clinical specimens (for example, core needle biopsies).

3 mmogram and a target for stereotactic breast needle biopsy.

4 t as the one originally diagnosed with LN at needle biopsy.

5 cancer and a target for stereotactic breast needle biopsy.

6 kidney transplant is currently diagnosed by needle biopsy.

7 3 benign papillary lesions diagnosed at core-needle biopsy.

8 ed on tissue obtained with image-guided core-needle biopsy.

9 c findings at the time of lumpectomy or core-needle biopsy.

10 the morbidity and mortality associated with needle biopsy.

11 Two small cancers were completely removed at needle biopsy.

12 tients, open biopsy was performed after core-needle biopsy.

13 graft surgery was obtained by subepicardial needle biopsy.

14 of diagnostic techniques, particularly core needle biopsy.

15 as atypical ductal hyperplasia (ADH) by core needle biopsy.

16 the cellular resolution afforded by invasive needle biopsy.

17 thorax in patients undergoing CT-guided core needle biopsy.

18 hat would result in a recommendation of fine-needle biopsy.

19 reliability of diagnoses obtained with core-needle biopsy.

20 neumothorax after percutaneous transthoracic needle biopsy.

21 malignant changes in the vicinity of a core needle biopsy.

22 nucleic acid yields from imaging-guided core needle biopsy.

23 on of (68)Ga-PSMA PET/CT in conjunction with needle biopsy.

24 out metastatic disease and diagnosed by core needle biopsy.

25 To assess the complications of core-needle biopsy.

26 y were negatively correlated with receipt of needle biopsy.

27 redicated on the results of a patient's fine-needle biopsy.

28 kemia antigen CD34, coupled with a "magnetic needle" biopsy.

29 m 23 patients undergoing stereotactic breast needle biopsies.

30 l open biopsy, 44 kidneys in 31 patients had needle biopsies.

31 subpopulation of tissue specimens sampled by needle biopsies.

32 ility of this assay for analyzing small core needle biopsies.

33 n-and are therefore suitable for analysis of needle biopsies.

34 stic sampling as an attractive surrogate for needle biopsies.

35 umbers of viable cells when compared to core needle biopsies.

36 itial surgical procedure: 9 open biopsies, 4 needle biopsies, 1 partial nephrectomy).

37 After US-guided core-needle biopsy, 115 (58%) of 198 patients were treated co

38 Twenty-four studies used core-needle biopsy; 44, vacuum-assisted biopsy; 21, both core

39 pared with those with ADH diagnosed via core needle biopsy (5%; 95% CI, 2.2%-8.9%).

40 tic yield (71.5% [40/56]) compared with core-needle biopsy (50% [17/34] P = .04) and fine needle aspi

41 almost three times as high as those for core-needle biopsy ($698 vs $243).

42 Among 572 scheduled stereotactic core-needle biopsies, 89 cases (16%) in 88 patients were canc

43 thermodilution blood flow measurements, and needle biopsies allowed the assessment of muscle oxygen

44 uided transsternal approach for coaxial core-needle biopsy allows safe access to masses in various lo

45 18 cell lines and 3 patient tumors from fine needle biopsies and assembled them with median coverages

46 Numerous pathologic characteristics in needle biopsies and preoperative clinical findings were

47 Ultimately, we aim to guide percutaneous needle biopsies and provide a minimally invasive method

48 easibility profile similar to that of single-needle biopsy and (b) an absence of serious adverse even

49 high-risk (for cancer) breast tissue at core-needle biopsy and had undergone subsequent surgery or fo

50 problems and limitations of prognostic fine needle biopsy and molecular classifications.

51 uracy of other interventions, including core-needle biopsy and needle-localized open surgical biopsy.

52 mputed tomographic (CT)-guided transthoracic needle biopsy and otherwise would have required chest tu

53 planning and guiding subsequent percutaneous needle biopsy and patient care.

54 eral anesthesia in 14 patients who underwent needle biopsy and radio-frequency treatment.

55 timate adipocyte size from an adipose tissue needle biopsy and routine quantitative real-time PCR mea

56 del is essential to prevent unnecessary fine-needle biopsy and thyroid surgery.

57 operative MR imaging combined with MR-guided needle biopsy and/or MR-guided lesion localization or br

58 generate 2 x 10(6) cells in 5 to 6 days from needle biopsies, and can generate cultures from cryopres

59 Open thoracotomies, needle biopsies, and indwelling pleural catheters were e

60 nal procedures such as radiation therapy and needle biopsy, and might help simplify the hardware of t

61 miles from a radiologic facility performing needle biopsy, and no mammogram within 60 days before co

62 f, starting with its diagnosis, reporting on needle biopsy, and reviewing how the most frequently use

63 ic findings, the histologic findings at core-needle biopsy, and the findings at subsequent surgical e

64 of US-guided FNA is similar to that of core needle biopsy, and there were no complications in this s

65 Definitive surgical, core-needle biopsy, and/or follow-up information was availabl

66 r Child Health study proposes a percutaneous needle biopsy approach to obtain postmortem samples, rat

67 Patients underwent pretreatment core needle biopsy; archival tumor samples were also obtained

68 cancers (Gleason pattern 3, G3) detected on needle biopsies are generally viewed as indolent and sui

69 Needle biopsies are invasive and associated with patient

70 and computed tomography-guided transthoracic needle biopsy are commonly used in patients undergoing b

71 ular fine-needle aspiration and percutaneous needle biopsy are feasible alternatives in selected grou

72 with pure LN of a low-risk type diagnosed at needle biopsy are strongly encouraged to undergo a yearl

73 Eight of 18 lesions diagnosed with automated needle biopsy as ADH were determined at surgery to be br

74 Nine of 55 lesions diagnosed with automated needle biopsy as DCIS were diagnosed as infiltrating duc

75 d OCM, which has the potential to guide core needle biopsies, assess surgical margins, and evaluate n

76 monary nodules and underwent a transthoracic needle biopsy at the interventional unit from January 1,

77 in human vastus lateralis muscle obtained by needle biopsy basally and after insulin infusion in four

78 n cases referred for excisional biopsy after needle biopsy because of atypia or discordance, final su

79 Percutaneous core-needle biopsy can be an effective alternative to open bi

80 Transvitreal and transscleral needle biopsy can result in complications including vitr

81 However, core needle biopsy (CNB) has become widely accepted as part o

82 pared with the Gleason score (GS) after core needle biopsy (CNB) in patients with low, medium and hig

83 Percutaneous core needle biopsy (CNB) is optimal for minimizing surgery fo

84 ELs) are a common histologic finding on core needle biopsy (CNB) of the breast.

85 Core needle biopsy (CNB) sampling is known to be inexpensive

86 biopsies (FNAB) controlled with CT and core-needle biopsy (CNB) under real-time CT fluoroscopy guida

87 olumnar cell lesions (CCLs) in a breast core needle biopsy (CNB).

88 surgeries was 33.7% for patients undergoing needle biopsy compared with 69.6% for those who did not

89 After needle biopsy, computed tomography (CT)-guided percutane

90 Low-strength evidence showed that core-needle biopsies conducted under stereotactic guidance wi

91 Furthermore, mock needle biopsy cores containing foci of prostate cancer e

92 nd lipidomic profiles of routine breast core needle biopsies could be obtained effectively.

93 Stereotactic core needle biopsy decreases the cost of diagnosis, but its i

94 Studies that compared core-needle biopsy diagnoses with open surgical diagnoses or

95 cheduled for an initial or repeated prostate needle biopsy due to suspicious digital rectal examinati

96 However, despite stereotactic guidance, core needle biopsy fails to retrieve microcalcifications in u

97 findings in the surgical specimens when core-needle biopsy findings indicated malignancy or follicula

98 imaging-guided 9-gauge vacuum-assisted core-needle biopsy findings of 85 lesions in 75 patients aged

99 Transthoracic needle biopsy findings were positive for cancer in 40 ca

100 least one year; 76 (96.2%) had negative core-needle biopsy findings, and 74 (97.3%) of these remained

101 To determine the reliability of the core-needle biopsy findings, we compared the diagnosis from t

102 ing lobectomies in patients with benign core-needle biopsy findings.

103 Fine-needle biopsy (FNB) became a critical part of thyroid no

104 spectroscopy guidance of stereotactic breast needle biopsies for microcalcifications.

105 Fine needle biopsy for assignment of gene expression profile

106 for spectroscopic validation of breast core needle biopsy for detection of microcalcifications that

107 Following a fine-needle biopsy for later confirmation of APA diagnosis, a

108 tification of cancerous lesions that require needle biopsy for minimally invasive tissue sampling and

109 The sensitivity of core-needle biopsy for the diagnosis of thyroid cancer was lo

110 01 patients who underwent transthoracic core needle biopsy for the KEYNOTE-001 (MK-3475) clinical tri

111 xpression profiling was performed on 50 core needle biopsies from 18 breast cancer patients using Aff

112 islets in pancreatectomies and percutaneous needle biopsies from 55 whole pancreas allografts.

113 As a demonstration, we analyze core needle biopsies from ERBB2 positive breast cancers befor

114 at coexpress E-cadherin and vimentin in core-needle biopsies from patients with various advanced meta

115 chilles tendon by means of ultrasound-guided needle biopsies from the healing area of the Achilles te

116 els, human skeletal muscle cells obtained by needle biopsy from normal control subjects were grown in

117 om diagnostic tumor biopsies, including core-needle biopsies frozen in a non-viable format, to enable

118 First, core needle biopsies generate little tissue material, and sev

119 of 110 patients (73.6%) in the transthoracic needle biopsy group (absolute difference, 5.4 percentage

120 A single needle biopsy had a 15% chance and virtual biopsy had a

121 Multisite stereotactic core needle biopsy had a positive effect on patient care in 2

122 The diagnosis of prostate cancer on needle biopsy has been refined because of the recent dis

123 grade prostatic intraepithelial neoplasia on needle biopsy has decreased to the point at which this a

124 aging and medical technology, CT-guided core needle biopsy has largely replaced fluoroscopic-guided f

125 s) are deadly paediatric brain tumours where needle biopsies help guide diagnosis and targeted therap

126 d ultrasound, physical examination, and fine needle biopsy if required to evaluate thyroid nodularity

127 and-guided CNB, image-guided vacuum assisted needle biopsy, image-guided fine needle aspiration, punc

128 e using 25-gauge vitrectomy as an adjunct to needle biopsy immediately before brachytherapy to minimi

129 This retrospective study reviewed 195 core-needle biopsies in 178 patients.

130 Core-needle biopsy in comparison to fine-needle aspiration bi

131 specificity, and accuracy of US-guided core needle biopsy in differentiating benign from malignant l

132 nsitivity, specificity, and accuracy of core-needle biopsy in the detection of malignant neoplasms we

133 012, the proportion of ADH diagnosed by core needle biopsy increased from 21% to 77%.

134 Core needle biopsy increases patient satisfaction and reduces

135 Background Percutaneous CT-guided lung core-needle biopsy is a frequently performed and generally sa

136 Use of needle biopsy is a proposed quality measure in the diagn

137 CT-guided percutaneous needle biopsy is a safe, alternative method for obtainin

138 Conclusion Image-guided transthoracic core needle biopsy is an effective method for obtaining tissu

139 Image-guided 25-gauge needle biopsy is both feasible and safe.

140 Multisite stereotactic core needle biopsy is feasible, safe, and may influence treat

141 odel referenced in Kwak et al., wherein fine-needle biopsy is recommended for TIRADS 4A or higher.

142 er of suspicious ultrasound features, a fine-needle biopsy is recommended.

143 esions is necessary before stereotactic core-needle biopsy is scheduled.

144 Stereotactic core needle biopsy is the diagnostic procedure of choice for

145 Needle biopsy is underused in the United States, resulti

146 d approach to tumor sampling, often invasive needle biopsy, is unable to fully capture the spatial st

147 Large-core needle biopsy (LCNB) has become an alternative to surgic

148 tereotactic, 14-gauge, automated, large-core needle biopsy (LCNB) was performed in 483 consecutive no

149 At core-needle biopsy, lesions were diagnosed as papilloma (n =

150 At MR imaging-guided core-needle biopsy, malignancy was identified in 52 (61%) les

151 earning model and test the performance on 44 needle biopsy material (110 slides) from a local annotat

152 monitoring AMACR activity levels in prostate needle biopsies may have clinical applications.

153 tallic clips placed during stereotactic core-needle biopsy may differ substantially from the location

154 Current bronchoscopy and transthoracic needle biopsy methods yield a sensitivity of 70% to 90%

155 atic disease with the use of prognostic fine needle biopsy, Monosomy 3 a risk factor for metastatic d

156 Disease progression was verified at needle biopsy (n = 16), follow-up imaging (n = 14), and/

157 ne-needle aspiration (n = 55), 14-gauge core-needle biopsy (n = 81), or both (n = 14).

158 y (standard care; n=25) or CT-guided cutting needle biopsy (n=25).

159 DNA was extracted from fine needle biopsies of 73 primary breast cancers and 19 meta

160 emistry on formalin fixed, paraffin embedded needle biopsies of kidney and pancreas allografts.

161 Findings at 209 consecutive core-needle biopsies of lesions of the thyroid gland in 198 p

162 ODS: From January, 2012 to May 2013, 76 core-needle biopsies of lung and mediastinum tumors were cond

163 ations were compared with measurements on 10 needle biopsies of normal liver and four tumor biopsies.

164 Needle biopsies of skeletal muscle (vastus lateralis) we

165 Needle biopsies of the liver were performed on a cross-s

166 Four hundred twenty-three needle biopsies of the lung were performed in 390 patien

167 Transrectal ultrasound guided needle biopsies of the prostate are routinely performed

168 Needle biopsies of vastus lateralis muscle were obtained

169 Needle biopsies of vastus lateralis muscle were taken fr

170 r can be normalized after prolonged culture, needle biopsies of vastus lateralis were obtained from 8

171 Tissue collected by core needle biopsy of a left internal jugular lymph node demo

172 in recurrent disease is usually made by core needle biopsy of a single lesion, which may not represen

173 Nodal ultrasonography with needle biopsy of abnormal lymph nodes helps to define th

174 vances enabling computer-guided stereoscopic needle biopsy of calcified foci, histopathologic diagnos

175 US technique was used to identify and guide needle biopsy of enlarged supraclavicular lymph nodes (>

176 able with published results of transthoracic needle biopsy of larger lesions.

177 9.4%) would not make it safe to avoid a core needle biopsy of lesions that undergo contrast enhanceme

178 Transthoracic needle biopsy of mediastinal lymphadenopathy is a safe,

179 ty-five patients underwent stereotactic core needle biopsy of more than one site.

180 y 1995, 302 patients underwent transthoracic needle biopsy of pulmonary lesions.

181 Transthoracic needle biopsy of small pulmonary nodules can produce dia

182 Needle biopsy of such lesions, however, is best performe

183 es that nuclear medicine guided stereotactic needle biopsy of the breast in patients with positive sc

184 Ultrasound-guided core needle biopsy of the breast mass diagnoses an invasive d

185 dle track created by stereotactic large-core-needle biopsy of the breast.

186 elected cases by those performing large-core-needle biopsy of the breast.

187 Transthoracic needle biopsy of the hilum or mediastinum was performed

188 ing the impact of invasive percutaneous core needle biopsy of the kidney allograft on diagnostic biom

189 Thirty-eight patients underwent percutaneous needle biopsy of the liver with chemical measurement of

190 is could be histologically diagnosed without needle biopsy of the liver.

191 ory-type material obtained by US-guided fine-needle biopsy of the pleural lesion were positive for My

192 the injection site were confirmed by sextant needle biopsy of the prostate at 2 weeks.

193 ansrectal ultrasound guided systemic sextant needle biopsy of the prostate has been the procedure of

194 Sextant needle biopsy of the prostate was obtained at 2 (cohort

195 Core-needle biopsy of the renal cortex obtained during surgic

196 US-guided core-needle biopsy of the thyroid gland is a safe outpatient

197 Core-needle biopsy of thyroid nodules is effective because it

198 ankle dorsiflexion (ADF) and then obtained a needle biopsy of tibialis anterior (TA) to analyze splic

199 and knowledge regarding downstream impact of needle biopsy on breast cancer care is incomplete.

200 Diagnosis of ADH on core needle biopsy or excisional biopsy in women undergoing m

201 sk for breast cancer and should undergo core-needle biopsy or needle localization with surgical biops

202 2 on gene-expression profiling, detected by needle biopsy or solid tumor biopsy.

203 dle aspiration and tissues obtained via core needle biopsy or surgery.

204 5% CI, 1.04 to 4.13) and completion of first needle biopsy (OR, 3.02; 95% CI, 1.76 to 5.18) were asso

205 ed biopsies and 8.6 months for the automated needle biopsies (P < .0001).

206 Among 16 945 needle biopsies performed between April 1998 and August

207 in diagnostic techniques, specifically core needle biopsies performed under mammographic and ultraso

208 adiographs of the specimens obtained at core needle biopsy performed through the region of color leve

209 in the relative utilization of percutaneous needle biopsy (PNB) and imaging-guided percutaneous biop

210 issue classification during the percutaneous needle biopsy (PNB) of the liver.

211 fers a versatile, noninvasive alternative to needle biopsy procedures for the diagnosis or surveillan

212 tereotactic- and ultrasonography-guided core-needle biopsy procedures seem to be almost as accurate a

213 sion, in real-time, during stereotactic core needle biopsy procedures.

214 ted in patients who present with palpable or needle biopsy-proven axillary metastases, patients with

215 Surgeon-level interventions may improve needle biopsy rates and, accordingly, quality of care.

216 a false-positive screening without and with needle biopsy, respectively.

217 In 105 (74%) patients, core-needle biopsy results were concordant with results from

218 In 36 (26%) patients, inaccurate core-needle biopsy results were obtained: In nine, results we

219 Needle biopsy revealed a cytokeratin 20-positive, high-g

220 Ultrasound-guided core needle biopsy revealed an infiltrating ductal carcinoma

221 Needle biopsies samples were taken from the vastus later

222 on was detectable for all genes in malignant needle biopsy samples (AUC: 0.80 to 0.98), confirming pr

223 ein synthesis in human skeletal muscle using needle biopsy samples and applied this technique to eluc

224 ained to detect and grade cancer in prostate needle biopsy samples at a ranking comparable to that of

225 Overall mean number of core needle biopsy samples obtained was 7.9 samples.

226 r regular quantification of steroids in core needle biopsy samples of breast tissue to inform dosage

227 gs were compared with histopathology of core needle biopsy samples or with ultrasound follow-up data

228 ole sections, paired surgical resection/core needle biopsy samples, and paired samples from 69 patien

229 agnostics on patient blood, bone marrow, and needle biopsy samples.

230 jected onto other slides from nephrectomy or needle biopsy samples.

231 may facilitate the analysis of miRNA in fine-needle-biopsy samples and even in single cells without e

232 echniques include stereotactic 14-gauge core-needle biopsy (SC bx), stereotactic 11-gauge suction-ass

233 ed the differences between stereotactic core needle biopsy (SCNBx) and needle localization surgical b

234 ctal hyperplasia diagnosed with percutaneous needle biopsy should be managed with surgical excision.

235 apillary lesions diagnosed as benign at core-needle biopsy should be surgically excised because a sub

236 Large-core needle biopsy showed diffuse calcifications within expan

237 gnostic purposes involving preoperative fine-needle biopsy specimens as well as to define targetable

238 n of AMACR protein expression in 94 prostate needle biopsy specimens demonstrated 97% sensitivity and

239 A total of 151 pancreas transplant needle biopsy specimens from 57 patients were evaluated.

240 xpression profile analysis of formalin-fixed needle biopsy specimens from the livers of 216 patients

241 erial tissue sections from paraffin-embedded needle biopsy specimens obtained at approximately 1 hr o

242 tion, PDGFRalpha expression in pre-operative needle biopsy specimens predicted poor overall survival

243 ; however, the efficacy of snRNA-seq on core needle biopsy specimens remains to be proven.

244 be useful in the interpretation of prostate needle biopsy specimens that are diagnostically challeng

245 chain reaction evidence of JCV infection in needle biopsy specimens with and without viral nephropat

246 Formalin-fixed human breast cancer core-needle biopsy specimens, were embedded, lipid-cleared, a

247 cers assigned Gleason scores to the prostate needle biopsy specimens.

248 Foam cell arteriopathy was rarely seen in needle biopsy specimens.

249 ity of AMACR was evaluated using 94 prostate needle biopsy specimens.

250 reached by the histological analysis of core-needle biopsy specimens.

251 y with which florid duct lesions are seen in needle-biopsy specimens of the liver was assessed in pat

252 computed tomography, FDG-PET, transthoracic needle biopsy, surgery, and watchful waiting.

253 s, pairing RNA samples from control prostate needle biopsy taken before intervention to RNA from the

254 When directly compared with the traditional needle biopsy technique, NMR was found to be more precis

255 through the application of the percutaneous needle biopsy technique.

256 for severe complications is lower with core-needle biopsy than with open surgical procedures (<1% vs

257 allow for the identification of G3 tumors on needle biopsies that are truly indolent versus those tha

258 t lesions (HRLs) diagnosed with image-guided needle biopsy that require surgical excision to be disti

259 esions entirely removed at percutaneous core needle biopsy that required wider excision underwent fre

260 rmed by computed tomography (CT)-guided core needle biopsy that was performed 2-4 weeks before cryoab

261 Patients underwent MR imaging and fine-needle biopsy (the reference standard).

262 tomography (CT)-guided coaxial transthoracic needle biopsy, the authors fashioned an 18-gauge experim

263 plications, the probability of nondiagnostic needle biopsy, the sensitivity of computed tomography, a

264 grade prostatic intraepithelial neoplasia on needle biopsy--the most common precursor lesion to prost

265 hrough 4, among the 6706 men who underwent a needle biopsy, there were 220 tumors with a Gleason scor

266 tissue sites from fresh stereotactic breast needle biopsy tissue cores from 33 patients, including 5

267 We applied a new, needle biopsy tissue microarray (TMA) technique to study

268 includes the first xenografts generated from needle biopsy tissue obtained at diagnosis.

269 and 177 tissue samples (ie, resected or core-needle biopsied tissues).

270 , as well as measurements of tumor volume on needle biopsy to enhance the prediction in men undergoin

271 findings, fibrin bands or collagen, and core needle biopsy tract at microscopy.

272 Superimposing the recorded needle biopsy trajectories upon magnetic resonance/trans

273 he great increase in the utilization of core needle biopsies under mammographic and ultrasonographic

274 g the contribution of a patient's surgeon to needle biopsy use, and knowledge regarding downstream im

275 g nucleic acid yields in CT-guided lung core needle biopsies used for genomic analysis, there should

276 hat CNA burden can be measured in diagnostic needle biopsies using low-input whole-genome sequencing,

277 from patients undergoing stereotactic breast needle biopsy, using a compact clinical Raman system.

278 Cost savings of stereotactic core needle biopsy vary in subgroups of patients defined acco

279 cer associated with ADH diagnosed using core needle biopsy vs excisional biopsy.

280 10 cases, an ultrasound-guided percutaneous needle biopsy was attempted on a protocol basis 10 days

281 Core-needle biopsy was performed at a tertiary care instituti

282 Needle biopsy was performed because of mammographic calc

283 aphy, fine-needle aspiration biopsy, or core-needle biopsy was performed before a definitive diagnosi

284 For each lesion, image-guided core-needle biopsy was performed immediately after PET mammog

285 992 through February 1995, stereotactic core needle biopsy was performed in 356 women with 405 nonpal

286 Fourteen-gauge, automated needle biopsy was performed in 73 of these 113 lesions;

287 An ultrasound-guided Tru-Cut needle biopsy was performed, and histopathologic data we

288 Needle biopsy was used in 68.4% (n = 61,353) of all pati

289 specificity, and accuracy of US-guided core-needle biopsy were calculated.

290 reast cancer was initially diagnosed by core-needle biopsy were more likely than women with cancer in

291 based on histological evaluation of prostate needle biopsies, which have high false negative rates.

292 1780 women with diagnosis of primary DCIS on needle biopsy who were alive and free of invasive breast

293 Sextant prostate needle biopsies with ultrasound guidance.

294 Five patients also underwent core-needle biopsy with a coaxially introduced 20-gauge needl

295 One hundred eleven cases of core-needle biopsy with clip deployment were reviewed.

296 eve that biopsy procedures - especially core needle biopsies - with CEUS assistance are potent tools

297 io (HR) of 3.0 (95% CI, 2-4.5) and, via core needle biopsy, with an adjusted HR of 2.2 (95% CI, 1.5-3

298 s author does not recommend a routine repeat needle biopsy within the first year following the diagno

299 sultation before versus after biopsy, use of needle biopsy (yes or no), and number of surgeries for c

300 Core-needle biopsy yielded a diagnosis for 179 (91.7%) nodule